ARTA WANTS Ivermectin in fight vs. Covid-19

Compassionate Special Permit

The controversial drug Ivermectin could be used as a prophylaxis in the country’s battle against Covid-19 after the Food and Drug Administration (FDA) on Monday disclosed that it is eligible for compassionate special permit (CSP)

FDA Director-General Eric Domingo, during ‘Laging Handa’ press briefing, said that the medication — originally used as an anti-parasitic drug — may be reviewed for issuance of CSP as it is considered an investigational drug against the deadly virus.

He said any medical specialist who wants to legally distribute the drug as a prophylaxis and early treatment for Covid-19 may apply for registration in the FDA.

Anti-Red Tape Authority Director General Jeremiah Belgica

FDA ordered to expedite application process for drug

Ivermectin for COVID-19: Worth a Shot? | MedPage Today

 March 30, 2021

MANILA – The Anti-Red Tape Authority (ARTA) is urging the Food and Drug Administration (FDA) to expedite its processing of applications for the use of Ivermectin, an anti-parasitic drug undergoing trials for possible treatment of Covid-19 symptoms.This, after the FDA announced earlier Monday… Read More

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s